Ghazaleh Tabatabai

Ghazaleh Tabatabai

UNVERIFIED PROFILE

Are you Ghazaleh Tabatabai?   Register this Author

Register author
Ghazaleh Tabatabai

Ghazaleh Tabatabai

Publications by authors named "Ghazaleh Tabatabai"

Are you Ghazaleh Tabatabai?   Register this Author

91Publications

1891Reads

28Profile Views

Integrative assessment of brain and bone invasion in meningioma patients.

Radiat Oncol 2019 Jul 29;14(1):132. Epub 2019 Jul 29.

Department of Radiation Oncology, University Hospital Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-019-1341-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664715PMC
July 2019

Glioblastoma: State of the Art and Future Perspectives.

Cancers (Basel) 2019 Jul 31;11(8). Epub 2019 Jul 31.

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11081091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721299PMC
July 2019

[Challenges and future perspectives in neuro-oncology].

Nervenarzt 2019 Jun;90(6):594-600

Neurologische Klinik, Hirntumorzentrum, UniversitätsSpital Zürich, Universität Zürich, Zürich, Schweiz.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00115-019-0716-4DOI Listing
June 2019

[Neuro-Oncology].

Nervenarzt 2019 Jun;90(6):567

Zentrum für Neuroonkologie, Interdisziplinäre Sektion, Universitätsklinik Tübingen, Eberhard Karls-Universität Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00115-019-0732-4DOI Listing
June 2019

Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas.

Brain Pathol 2019 05 1;29(3):321-324. Epub 2019 Feb 1.

Center for CNS Tumors, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bpa.12709
Publisher Site
http://dx.doi.org/10.1111/bpa.12709DOI Listing
May 2019

High frequency of H3 K27M mutations in adult midline gliomas.

J Cancer Res Clin Oncol 2019 Apr 4;145(4):839-850. Epub 2019 Jan 4.

Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, 72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-018-02836-5
Publisher Site
http://dx.doi.org/10.1007/s00432-018-02836-5DOI Listing
April 2019

Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.

Neuro Oncol 2019 Apr 23. Epub 2019 Apr 23.

Interdisciplinary Division of Neuro-Oncology, Departments of Neurology and Neurosurgery, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noz071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620634PMC
April 2019

Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells.

Neurosignals 2017 1;25(1):26-38. Epub 2017 Sep 1.

Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000480643DOI Listing
March 2019

Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma.

Mol Ther Oncolytics 2019 Mar 31;12:147-161. Epub 2018 Dec 31.

Interdisciplinary Division of Neuro-Oncology, Hertie Institute for Clinical Brain Research, Departments of Neurology and Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen 72076, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omto.2018.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365369PMC
March 2019

Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas.

Neuro Oncol 2019 Jan;21(Supplement_1):i2-i3

Division of Neurosurgery, University Health Network, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noy181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347075PMC
January 2019

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma.

Int J Endocrinol 2018 9;2018:1763735. Epub 2018 Dec 9.

Center for CNS Tumors, Comprehensive Cancer Center Tuebingen-Stuttgart, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/1763735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304820PMC
December 2018

Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.

Clin Neuroradiol 2018 Sep 9;28(3):421-428. Epub 2017 May 9.

Diagnostic and Interventional Neuroradiology, Department of Radiology, Eberhard Karls University, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00062-017-0590-zDOI Listing
September 2018

The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis.

World Neurosurg 2017 Oct 18;106:615-624. Epub 2017 Jul 18.

Department of Neurosurgery, University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany; Center for CNS Tumors, Comprehensive Cancer Center Tuebingen Stuttgart, University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2017.07.034DOI Listing
October 2017

Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas.

Oncotarget 2017 Oct 3;8(50):87124-87135. Epub 2017 Aug 3.

Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19894DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675620PMC
October 2017

In vivo molecular profiling of human glioma using diffusion kurtosis imaging.

J Neurooncol 2017 01 7;131(1):93-101. Epub 2016 Sep 7.

Department of Neuroradiology, Eberhard Karls University, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2272-0DOI Listing
January 2017

Risk Factors of Preoperative and Early Postoperative Seizures in Patients with Meningioma: A Retrospective Single-Center Cohort Study.

World Neurosurg 2017 Jan 21;97:538-546. Epub 2016 Oct 21.

Department of Neurosurgery, Eberhard Karls University of Tübingen, University Hospital Tübingen, Tübingen, Germany; Neuro-Oncology Center, Comprehensive Cancer Center Tübingen, Eberhard Karls University of Tübingen, University Hospital Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2016.10.062DOI Listing
January 2017

Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.

Neuro Oncol 2016 12 10;18(12):1610-1621. Epub 2016 Jun 10.

Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland (D.M., M.W., E.S.S., K.S., G.T., H.S.); Center for Neuroscience, University of Zurich, Zurich, Switzerland (M.W., G.T.); Interdisciplinary Center for Bioinformatics, University of Leipzig, Leipzig, Germany (E.W., H.B.); Institute of Neuropathology, Heinrich Heine University, Düsseldorf, Germany (G.R.); German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, partner site, Essen/Düsseldorf, Germany (G.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693192PMC
December 2016

The role of integrins in primary and secondary brain tumors.

Histol Histopathol 2016 Oct 14;31(10):1069-78. Epub 2016 Apr 14.

Department of Pathology, University Medical Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-11-7741DOI Listing
October 2016

ATRX immunostaining predicts IDH and H3F3A status in gliomas.

Acta Neuropathol Commun 2016 06 16;4(1):60. Epub 2016 Jun 16.

Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Calwerstr. 3, D-72076, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40478-016-0331-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910252PMC
June 2016

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.

Neuro Oncol 2016 Apr 27;18(4):549-56. Epub 2016 Jan 27.

Department of Neurosurgery, Ludwig-Maximilians University Munich, Munich, Germany (B.S., J.C.T.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W., G.T., H.-G.W.); Department of Neurology, University Hospital Tübingen, Tübingen, Germany (G.T.); Department of Neurosurgery, University Hospital Frankfurt, Frankfurt am Main, Germany (C.S.); Department of Neurology, University Hospital Regensburg, Regensburg, Germany (P.H.); Department of Neurosurgery, University Hospital Düsseldorf, Düsseldorf, Germany (M.C.S.); Department of Neurology, University Hospital Bonn, Bonn, Germany (U.H.); Department of Neurosurgery, University Hospital Saarland, Homburg/Saar, Germany (R.K.); Department of Neurology, Knappschaftskrankenhaus Bochum, Bochum, Germany (U.S.); Department of Oncology, Vienna General Hospital, Vienna, Austria (C.M.); Institute of Neuropathology, University Hospital Düsseldorf, Düsseldorf, Germany (G.R.); Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany (W.W.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/early/2016/
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov326DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799687PMC
April 2016

Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition.

Oncotarget 2015 Sep;6(26):22480-95

Laboratory of Molecular Neuro-Oncology, Department of Neurology and Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673177PMC
September 2015

Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.

Neuro Oncol 2015 Feb 27;17(2):254-65. Epub 2014 Aug 27.

Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288525PMC
February 2015

In vivo visualization of prostate-specific membrane antigen in glioblastoma.

Eur J Nucl Med Mol Imaging 2015 Jan 8;42(1):170-1. Epub 2014 Oct 8.

Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-014-2921-5DOI Listing
January 2015

The management of lomustine overdose in malignant glioma patients.

Neurooncol Pract 2014 Dec 12;1(4):178-183. Epub 2014 Sep 12.

Department of Neurology, University Hospital Zurich, Zurich, Switzerland (H.-G.W., I.T., A.P., M.W., G.T.); Department of Medical Oncology , University Hospital Zurich , Zurich , Switzerland (C.R.); Neuroscience Center Zurich , University of Zurich and ETH Zurich , Zurich , Switzerland (H.-G.W., I.T., A.P., M.W., G.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npu023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369719PMC
December 2014

Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.

Stem Cells 2014 Oct;32(10):2583-95

Brain Research Institute, University of Zurich/Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.1776DOI Listing
October 2014

Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma.

Brain 2014 Feb 18;137(Pt 2):433-48. Epub 2013 Dec 18.

1 Department of Neurology, Laboratory of Molecular Neuro-Oncology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awt333DOI Listing
February 2014

Malignant astrocytoma in elderly patients: where do we stand?

Curr Opin Neurol 2013 Dec;26(6):693-700

aDepartment of Neurology bDepartment of Medical Oncology, University Hospital Zurich, Zurich, Switzerland cDepartment of Neurooncology, National Center for Tumor Disease and Neurology Clinic, University Hospital Heidelberg, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000037DOI Listing
December 2013

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.

Neurology 2013 Oct 25;81(17):1515-22. Epub 2013 Sep 25.

From the Departments of Neuro-oncology (W.W., M.P., A.S., B.W., M. Weiler) and Neuropathology (A.v.D.), University of Heidelberg; German Cancer Consortium (DKTK) (W.W., B.W., M. Weiler), Clinical Cooperation Unit Neuro-oncology and Clinical Cooperation Unit Neuropathology (A.v.D.), German Cancer Research Center, Heidelberg; Department of Medical Biometry (C.M.), University of Tübingen; Institute for Medical Informatics, Statistics and Epidemiology (B.H., M.L.), University Leipzig; Departments of Neurosurgery (M.C.S.) and Neuropathology (G.R.), Heinrich-Heine-University and DKTK (G.R.), Düsseldorf; Department of Neurology (S.K.), University of Essen Medical School; Department of Neurosurgery (R.K.), Saarland University, Homburg, Germany; Department of Neurology (G.T., D.G., M. Weller), University Hospital Zurich, Switzerland; Department of Neurosurgery (M. Westphal), University Clinic Hamburg Eppendorf, Hamburg; Department of Neurosurgery (G.S.) and DKTK (G.S.), Technical University Dresden; and Department of Neurosurgery (M.S.), University of Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e3182a95680DOI Listing
October 2013

Integrin control of the transforming growth factor-β pathway in glioblastoma.

Brain 2013 Feb 31;136(Pt 2):564-76. Epub 2013 Jan 31.

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/aws351DOI Listing
February 2013

Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury.

Eur Heart J 2013 Jan 24;34(2):96-103. Epub 2012 Sep 24.

Cardiovascular Research, Institute of Physiology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehs331DOI Listing
January 2013

HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells.

J Neuroimmunol 2012 Sep 9;250(1-2):27-34. Epub 2012 Jun 9.

Department of Neurology, University Hospital Zürich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2012.05.010DOI Listing
September 2012

Clinical implications of molecular neuropathology and biomarkers for malignant glioma.

Curr Neurol Neurosci Rep 2012 Jun;12(3):302-7

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, Zurich 8091, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-012-0263-xDOI Listing
June 2012

The role of integrins in glioma biology and anti-glioma therapies.

Curr Pharm Des 2011 ;17(23):2402-10

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161211797249189DOI Listing
May 2012

Stem cell-mediated gene therapies for malignant gliomas: a promising targeted therapeutic approach?

Discov Med 2011 Jun;11(61):529-36

Laboratory of Molecular Neurooncology, University of Zurich, Switzerland.

View Article

Download full-text PDF

Source
June 2011

Glioblastoma stem cells.

Cell Tissue Res 2011 Mar 21;343(3):459-65. Epub 2011 Jan 21.

Laboratory of Molecular Neurooncology, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00441-010-1123-0
Publisher Site
http://dx.doi.org/10.1007/s00441-010-1123-0DOI Listing
March 2011

APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo.

Neuro Oncol 2011 Feb 22;13(2):155-64. Epub 2010 Dec 22.

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noq176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064626PMC
February 2011

Molecular diagnostics of gliomas: the clinical perspective.

Acta Neuropathol 2010 Nov 23;120(5):585-92. Epub 2010 Sep 23.

Department of Neurology, University Hospital Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00401-010-0750-6DOI Listing
November 2010

Targeting integrins in malignant glioma.

Target Oncol 2010 Sep 4;5(3):175-81. Epub 2010 Sep 4.

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11523-010-0156-3
Publisher Site
http://dx.doi.org/10.1007/s11523-010-0156-3DOI Listing
September 2010

Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

Future Oncol 2010 Sep;6(9):1407-14

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.10.113DOI Listing
September 2010

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma.

J Neurosurg 2010 Aug;113(2):280-5

Department of Neurosurgery, Indiana University, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2009.11.JNS09901DOI Listing
August 2010

GDF-15 contributes to proliferation and immune escape of malignant gliomas.

Clin Cancer Res 2010 Aug 9;16(15):3851-9. Epub 2010 Jun 9.

Laboratory of Molecular Neurooncology, Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0705DOI Listing
August 2010

Glioma tropism of lentivirally transduced hematopoietic progenitor cells.

Int J Oncol 2010 Jun;36(6):1409-17

Laboratory of Molecular Neurooncology, Department of General Neurology and Hertie Institute for Clinical Brain Research, University of Tubingen, Tubingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000626DOI Listing
June 2010

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro.

Neuro Oncol 2009 Dec;11(6):747-56

Department of Neurology, University Hospital of Tübingen, Hertie Institute for Clinical Brain Research, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1215/15228517-2009-012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802395PMC
December 2009

Primetime for antiangiogenic therapy.

Curr Opin Neurol 2009 Dec;22(6):639-44

Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0b013e328332ba28DOI Listing
December 2009

VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells.

Brain 2008 Oct 9;131(Pt 10):2579-95. Epub 2008 Aug 9.

Department of General Neurology, Laboratory of Molecular Neurooncology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awn182DOI Listing
October 2008

Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL.

J Neurochem 2008 Sep 24;106(6):2436-48. Epub 2008 Jul 24.

Laboratory of Molecular Neuro-Oncology, Department of General Neurology, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1471-4159.2008.05586.x
Publisher Site
http://dx.doi.org/10.1111/j.1471-4159.2008.05586.xDOI Listing
September 2008

Vertebral artery dissection presenting with ispilateral acute C5 and C6 sensorimotor radiculopathy: A case report.

Cases J 2008 Sep 3;1(1):139. Epub 2008 Sep 3.

Center of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1757-1626-1-139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538503PMC
September 2008

Synergistic antiglioma activity of radiotherapy and enzastaurin.

Ann Neurol 2007 Feb;61(2):153-61

Laboratory of Molecular Neurooncology, Department of General Neurology and Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.21057DOI Listing
February 2007

Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.

Brain 2006 Sep 10;129(Pt 9):2426-35. Epub 2006 Jul 10.

Laboratory of Molecular Neuro-Oncology, Department of General Neurology and Hertie Institute for Clinical Brain Research University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awl173DOI Listing
September 2006

Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.

Brain 2005 Sep 9;128(Pt 9):2200-11. Epub 2005 Jun 9.

Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awh563DOI Listing
September 2005

Primary amyloidoma of the brain parenchyma.

Arch Neurol 2005 Mar;62(3):477-80

Department of Neurology, Brain Tumor Center, Massachusetts General Hospital, Boston 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.62.3.477DOI Listing
March 2005

Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression.

Mol Cell Neurosci 2003 Nov;24(3):696-708

Institute of Neuropathology, University Hospital Zurich, CH 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1044-7431(03)00232-xDOI Listing
November 2003